Retrophin (RTRX) Setup Into DUET Data Remains Favorable - BMO

August 5, 2016 9:23 AM EDT Send to a Friend
BMO Capital analyst Do Kim reiterated an Outperform rating and raised his price target on Retrophin (NASDAQ: RTRX) to $28.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login